11 - 12 March 2026 | Sans Expo & Convention Centre, Singapore

Co-located Events

Attendees

Companies

Speakers

MESSAGE FROM THE ORGANISER

735 biopharma leaders, 107 expert speakers, and 62 leading exhibitors gathered across Biologics Manufacturing Asia 2026 and its co-located events - Clinical Trials Festival Asia, ADC Asia Congress, and BioSupply Chain Asia, held on 11–12 March at the Sands Expo and Convention Centre in Singapore. Together, these events formed one of the region’s most comprehensive gatherings for the biologics industry, bringing together leaders across development, manufacturing, clinical research, and supply chain, and reinforcing its position as a cornerstone event for the Asia-Pacific biologics ecosystem. The event brought together a diverse community of Big Pharma, regional biopharma manufacturers, CDMOs, CROs, technology providers, and solution innovators, creating a platform for industry leaders to exchange insights, explore partnerships, and address the evolving challenges of biologics development, manufacturing, and supply chains. With multiple co-located events covering biomanufacturing, supply chain, ADCs, and emerging biologics modalities, Biologics Manufacturing Asia remains the only platform that brings together the entire biologics ecosystem across the APAC region under one roof. This year, the event welcomed attendees from South Korea, Singapore, India, Indonesia, Malaysia, Australia, Japan, as well as Europe and the United States, reflecting its growing global reach and importance for companies looking to expand in Asia-Pacific.

Sincerely, IMAPAC

735 biopharma leaders, 107 expert speakers, and 62 leading exhibitors gathered across Biologics Manufacturing Asia 2026 and its co-located events - Clinical Trials Festival Asia, ADC Asia Congress, and BioSupply Chain Asia, held on 11–12 March at the Sands Expo and Convention Centre in Singapore. Together, these events formed one of the region’s most comprehensive gatherings for the biologics industry, bringing together leaders across development, manufacturing, clinical research, and supply chain, and reinforcing its position as a cornerstone event for the Asia-Pacific biologics ecosystem. The event brought together a diverse community of Big Pharma, regional biopharma manufacturers, CDMOs, CROs, technology providers, and solution innovators, creating a platform for industry leaders to exchange insights, explore partnerships, and address the evolving challenges of biologics development, manufacturing, and supply chains. With multiple co-located events covering biomanufacturing, supply chain, ADCs, and emerging biologics modalities, Biologics Manufacturing Asia remains the only platform that brings together the entire biologics ecosystem across the APAC region under one roof. This year, the event welcomed attendees from South Korea, Singapore, India, Indonesia, Malaysia, Australia, Japan, as well as Europe and the United States, reflecting its growing global reach and importance for companies looking to expand in Asia-Pacific.

Sincerely, IMAPAC

Attendee Breakdown

By Country

By Job Title

By Industry

Testimonials

“Good team, clever techniques to bring people in contact. Appreciate their effort and help.”

Product & Sales Manager, DrM Group, Switzerland

“Great experience! Nice speakers and exhibitions!”

CEO, HoneyBear Biosciences, Inc., Taiwan

“Friendly partnership, staff are very helpful.”

R&D Director, HyQure Biotech, China

“The team was very friendly and helpful. They were committed to scheduling 1-to-1 meetings and ensuring it went smoothly.”

BDM, SGS

“Good selection of topics and speakers.”

Senior Scientist, Bioprocessing Technology Institute, A*STAR

“Imapac always manages to invite some very inspiring speakers.”

Director, Asset Lead, EDDC

“Overall, we believe the event was very well organized and successful. From an exhibitor’s perspective, the arrangement of 1-to-1 meetings was particularly useful and added significant value.”

Business Development Director, Pfanstiehl

"Insights from industry leaders are valuable and cannot be found easily online"

Technical Steward, BioNTech, Singapore

“Thanks for organizing BioSupply Chain Asia, it was a good event and I have learnt a lot.”

Head of Singapore Expore Platform, Sanofi, Singapore

“Thank you so much for organizing such a well-run event. It was truly a pleasure to contribute, and I enjoyed the atmosphere and engagement from the audience during the event.”

Corporate Performance Specialist, Biofarma

“It was a very valuable conference experience. I was pleased to have the opportunity to present and discuss our technology with peers in the field, which led to several new and meaningful engagements. The meeting also offered a strong scientific programme, and it was inspiring to hear high-quality work from other groups. Beyond the content itself, the conference was especially useful for building new connections and opening the door to potential future collaborations.”

CTO, Singzyme, Singapore

“The conference provides a forum for latest sharing and networking among biopharma peers from different organisations. The panel discussions are particularly informative as they cover realistic, contemporaneous and first-hand sharing on opportunities and challenges facing the industry and organisations. One key highlight of the conference is the ABEA Night. This prestigious recognition highlights the outstanding contributions of individual leader advancing biopharma excellence in the Asia-Pacific region.”